CDNA – caredx, inc. (US:NASDAQ)
Stock Stats
News
Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies [Yahoo! Finance]
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.
CareDx, Inc (NASDAQ: CDNA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $14.00. They now have a "buy" rating on the stock.
Form 4 CareDx, Inc. For: May 14 Filed by: Bickerstaff George
Form POS AM CareDx, Inc.
Form 10-Q CareDx, Inc. For: Mar 31
Form 8-K CareDx, Inc. For: May 09
Form 4 CareDx, Inc. For: May 01 Filed by: Novack Jeffrey Adam
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.